In a notable development, the Government of Maharashtra and Haryana have exempted establishments from registration related requirements under the respective shops and establishments legislations (S&E Acts) after the enactment of the Occupational Safety, Health and Working Conditions Code, 2020 (OSH Code).
Through a series of notifications dated 8 May 2026, the Ministry of Labour and Employment, Government of India (Central Government) has brought into force the central rules under the labour codes (Rules), namely: (i) Code on Wages 2019 (Wages Code); (ii) Code on Social Security 2020 (SS Code); (iii) Occupational Safety, Health and Working Conditions Code 2020 (OSH Code); and (iv) Industrial Relations Code 2020 (IR Code).
Khaitan & Co advised Bain Capital in relation to the formation of a 50:50 joint venture between GSS India Opportunities AIF Scheme I (represented by its fund manager, Bain Capital Advisors (India) Pvt Ltd) and Brigade Enterprises Ltd, to develop and manage a 2 million square feet mixed-use project, comprising of a Grade A office space and a 5-star hotel in Bengaluru.
Khaitan & Co advised Bluecore Inc. in relation to its acquisition (including of its Indian subsidiary, Bluecore Software Pvt Ltd) by Insider One.
The Firm acted as deal counsel to Bluecore Inc. on this transaction for India.
Khaitan & Co advised Chalet Hotels Ltd (formerly Chalet Hotels Pvt Ltd) with the acquisition of 100% stake of Seasons Hotels Pvt Ltd owning a 144-room hotel ‘Inder Residency Resort & Spa, Udaipur’ in the state of Rajasthan from its shareholders for a total consideration of approximately INR 171 crores.
Khaitan & Co advised FMC Corporation on its divestment of India crop protection commercial business to Crystal Crop Protection Limited for a total consideration of USD 252 million.
Khaitan & Co acted as India counsel and advised Startek Inc. on cross-border merger of Startek Inc. with CCI Consulting FZCO and CCI Enterprises FZCO to create a scaled, PE-backed global customer experience (CX) platform. The transaction involved a complex multi-jurisdictional merger structure spanning the United States and UAE, with integration of multiple global subsidiaries.
Khaitan & Co is representing Amneal Pharmaceuticals, LLC (Amneal) as India counsels, alongside Simpson Thacher & Bartlett LLP in relation to its announced agreement to acquire 100% of Kashiv Biosciences LLC ("Kashiv"), a vertically integrated biopharmaceutical company incorporated in the United States of America, with 2 (two) subsidiaries in India (namely, Kashiv Biosciences Pvt Ltd and Kashiv Research Pvt Ltd), in a transaction with consideration that includes USD 375 million of cash and USD 375 mill
Khaitan and Co, alongside Linklaters LLP, advised Landis+Gyr AG on the divestiture of its EMEA business in India to AURELIUS Group (AURELIUS), a global alternative investment firm.
